The COVID-19 pandemic may lead to 95,000 additional tuberculosis (TB) deaths in India in five years due to disruptions to health services, and delays to diagnosis and treatment, according to new estimates published in the European Respiratory Journal.
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) and Lancaster University in England estimated additional TB deaths and cases in China, India and South Africa over the next five years.


